2024-04-012025-03-312025-03-31false10583051TICKHILL DENTAL & IMPLANT CENTRE LIMITED2025-09-02falseiso4217:GBPxbrli:pure105830512024-03-31105830512025-03-31105830512024-04-012025-03-31105830512023-03-31105830512024-03-31105830512023-04-012024-03-3110583051bus:SmallEntities2024-04-012025-03-3110583051bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3110583051bus:FullAccounts2024-04-012025-03-3110583051bus:PrivateLimitedCompanyLtd2024-04-012025-03-3110583051core:WithinOneYear2025-03-3110583051core:AfterOneYear2025-03-3110583051core:WithinOneYear2024-03-3110583051core:AfterOneYear2024-03-3110583051core:ShareCapital2025-03-3110583051core:SharePremium2025-03-3110583051core:RevaluationReserve2025-03-3110583051core:OtherReservesSubtotal2025-03-3110583051core:RetainedEarningsAccumulatedLosses2025-03-3110583051core:ShareCapital2024-03-3110583051core:SharePremium2024-03-3110583051core:RevaluationReserve2024-03-3110583051core:OtherReservesSubtotal2024-03-3110583051core:RetainedEarningsAccumulatedLosses2024-03-3110583051core:LandBuildings2025-03-3110583051core:PlantMachinery2025-03-3110583051core:Vehicles2025-03-3110583051core:FurnitureFittings2025-03-3110583051core:OfficeEquipment2025-03-3110583051core:NetGoodwill2025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2025-03-3110583051core:ListedExchangeTraded2025-03-3110583051core:UnlistedNon-exchangeTraded2025-03-3110583051core:LandBuildings2024-03-3110583051core:PlantMachinery2024-03-3110583051core:Vehicles2024-03-3110583051core:FurnitureFittings2024-03-3110583051core:OfficeEquipment2024-03-3110583051core:NetGoodwill2024-03-3110583051core:IntangibleAssetsOtherThanGoodwill2024-03-3110583051core:ListedExchangeTraded2024-03-3110583051core:UnlistedNon-exchangeTraded2024-03-3110583051core:LandBuildings2024-04-012025-03-3110583051core:PlantMachinery2024-04-012025-03-3110583051core:Vehicles2024-04-012025-03-3110583051core:FurnitureFittings2024-04-012025-03-3110583051core:OfficeEquipment2024-04-012025-03-3110583051core:NetGoodwill2024-04-012025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110583051core:ListedExchangeTraded2024-04-012025-03-3110583051core:UnlistedNon-exchangeTraded2024-04-012025-03-3110583051core:MoreThanFiveYears2024-04-012025-03-3110583051core:Non-currentFinancialInstruments2025-03-3110583051core:Non-currentFinancialInstruments2024-03-3110583051dpl:CostSales2024-04-012025-03-3110583051dpl:DistributionCosts2024-04-012025-03-3110583051core:LandBuildings2024-04-012025-03-3110583051core:PlantMachinery2024-04-012025-03-3110583051core:Vehicles2024-04-012025-03-3110583051core:FurnitureFittings2024-04-012025-03-3110583051core:OfficeEquipment2024-04-012025-03-3110583051dpl:AdministrativeExpenses2024-04-012025-03-3110583051core:NetGoodwill2024-04-012025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3110583051dpl:GroupUndertakings2024-04-012025-03-3110583051dpl:ParticipatingInterests2024-04-012025-03-3110583051dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3110583051core:ListedExchangeTraded2024-04-012025-03-3110583051dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3110583051core:UnlistedNon-exchangeTraded2024-04-012025-03-3110583051dpl:CostSales2023-04-012024-03-3110583051dpl:DistributionCosts2023-04-012024-03-3110583051core:LandBuildings2023-04-012024-03-3110583051core:PlantMachinery2023-04-012024-03-3110583051core:Vehicles2023-04-012024-03-3110583051core:FurnitureFittings2023-04-012024-03-3110583051core:OfficeEquipment2023-04-012024-03-3110583051dpl:AdministrativeExpenses2023-04-012024-03-3110583051core:NetGoodwill2023-04-012024-03-3110583051core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3110583051dpl:GroupUndertakings2023-04-012024-03-3110583051dpl:ParticipatingInterests2023-04-012024-03-3110583051dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3110583051core:ListedExchangeTraded2023-04-012024-03-3110583051dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3110583051core:UnlistedNon-exchangeTraded2023-04-012024-03-3110583051core:NetGoodwill2025-03-3110583051core:IntangibleAssetsOtherThanGoodwill2025-03-3110583051core:LandBuildings2025-03-3110583051core:PlantMachinery2025-03-3110583051core:Vehicles2025-03-3110583051core:FurnitureFittings2025-03-3110583051core:OfficeEquipment2025-03-3110583051core:AfterOneYear2025-03-3110583051core:WithinOneYear2025-03-3110583051core:ListedExchangeTraded2025-03-3110583051core:UnlistedNon-exchangeTraded2025-03-3110583051core:ShareCapital2025-03-3110583051core:SharePremium2025-03-3110583051core:RevaluationReserve2025-03-3110583051core:OtherReservesSubtotal2025-03-3110583051core:RetainedEarningsAccumulatedLosses2025-03-3110583051core:NetGoodwill2024-03-3110583051core:IntangibleAssetsOtherThanGoodwill2024-03-3110583051core:LandBuildings2024-03-3110583051core:PlantMachinery2024-03-3110583051core:Vehicles2024-03-3110583051core:FurnitureFittings2024-03-3110583051core:OfficeEquipment2024-03-3110583051core:AfterOneYear2024-03-3110583051core:WithinOneYear2024-03-3110583051core:ListedExchangeTraded2024-03-3110583051core:UnlistedNon-exchangeTraded2024-03-3110583051core:ShareCapital2024-03-3110583051core:SharePremium2024-03-3110583051core:RevaluationReserve2024-03-3110583051core:OtherReservesSubtotal2024-03-3110583051core:RetainedEarningsAccumulatedLosses2024-03-3110583051core:NetGoodwill2023-03-3110583051core:IntangibleAssetsOtherThanGoodwill2023-03-3110583051core:LandBuildings2023-03-3110583051core:PlantMachinery2023-03-3110583051core:Vehicles2023-03-3110583051core:FurnitureFittings2023-03-3110583051core:OfficeEquipment2023-03-3110583051core:AfterOneYear2023-03-3110583051core:WithinOneYear2023-03-3110583051core:ListedExchangeTraded2023-03-3110583051core:UnlistedNon-exchangeTraded2023-03-3110583051core:ShareCapital2023-03-3110583051core:SharePremium2023-03-3110583051core:RevaluationReserve2023-03-3110583051core:OtherReservesSubtotal2023-03-3110583051core:RetainedEarningsAccumulatedLosses2023-03-3110583051core:AfterOneYear2024-04-012025-03-3110583051core:WithinOneYear2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3110583051core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3110583051core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3110583051core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3110583051core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3110583051core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3110583051bus:Director12024-04-012025-03-3110583051core:FurnitureFittingsToolsEquipment2024-03-3110583051core:FurnitureFittingsToolsEquipment2024-04-012025-03-3110583051core:FurnitureFittingsToolsEquipment2025-03-31

TICKHILL DENTAL & IMPLANT CENTRE LIMITED

Registered Number
10583051
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

TICKHILL DENTAL & IMPLANT CENTRE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Mr N A S Aylott

Registered Address

12 Tentercroft Street
Lincoln
LN5 7DB

Place of Business

36 Sunderland Street

Tickhill

Doncaster

DN11 9QJ


Registered Number

10583051 (England and Wales)
TICKHILL DENTAL & IMPLANT CENTRE LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets380,00090,000
Tangible assets46,9936,291
86,99396,291
Current assets
Stocks51,3871,416
Debtors66,80220,205
Cash at bank and on hand26,69915,433
34,88837,054
Creditors amounts falling due within one year7(239,855)(236,991)
Net current assets (liabilities)(204,967)(199,937)
Total assets less current liabilities(117,974)(103,646)
Net assets(117,974)(103,646)
Capital and reserves
Called up share capital100100
Profit and loss account(118,074)(103,746)
Shareholders' funds(117,974)(103,646)
The financial statements were approved and authorised for issue by the Director on 2 September 2025, and are signed on its behalf by:
Mr N A S Aylott
Director
Registered Company No. 10583051
TICKHILL DENTAL & IMPLANT CENTRE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Interest income
Interest income is recognised using the effective interest rate method.
Operating leases
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made. Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows: Goodwill - 10% straight line
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Fixtures and fittings25-
Office Equipment-3
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
2.Average number of employees

20252024
Average number of employees during the year55
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 April 24250,000250,000
At 31 March 25250,000250,000
Amortisation and impairment
At 01 April 24160,000160,000
Charge for year10,00010,000
At 31 March 25170,000170,000
Net book value
At 31 March 2580,00080,000
At 31 March 2490,00090,000
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 246,59325,5029,43641,531
Additions4,492--4,492
Disposals(3,394)--(3,394)
At 31 March 257,69125,5029,43642,629
Depreciation and impairment
At 01 April 244,39922,0988,74335,240
Charge for year9338516932,477
On disposals(2,081)--(2,081)
At 31 March 253,25122,9499,43635,636
Net book value
At 31 March 254,4402,553-6,993
At 31 March 242,1943,4046936,291
5.Stocks

2025

2024

££
Raw materials and consumables387416
Work in progress1,0001,000
Total1,3871,416
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables1,5595,039
Other debtors3,45013,672
Prepayments and accrued income1,7931,494
Total6,80220,205
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables5,1124,191
Taxation and social security81,62434,080
Other creditors152,019197,620
Accrued liabilities and deferred income1,1001,100
Total239,855236,991